Check out Dendreon (Nasdaq - DNDN) for a comparasin of where we may be in 2-3 years if all goes to plan.
They are trading at close to $30!!!
IMO Cvac has far greater potential their product Provenge, as it has the potential to be used on multiple different Cancers and not just one cancer like Provenge.
Also in Primas favour, is the fact that DNDN has already taken Provenge through the rigerous FDA process and has been given approval. This should pave the way for Prima to do likewise, maybe even in a shorter timeframe?
But the thing that excites me the most about this stock is the people that are involved in bringing it to commercialisation...highly credible, highly connected people who WOULD NOT be involved if they thought there was a slight chance of failure!!!
Once this SPP is out of the way, IMO we will see rapid movement upwards in the SP, as biotechs tend to do.
but as always, best to dyor...good luck :)
Check out Dendreon (Nasdaq - DNDN) for a comparasin of where we...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.015(5.36%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.0¢ | $833.4K | 2.824M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 388130 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 39940 | 3 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |